Literature DB >> 22227879

Disability due to gouty arthritis.

Peter M ten Klooster1, Harald E Vonkeman, Mart A F J van de Laar.   

Abstract

PURPOSE OF REVIEW: Disability, or activity limitation, is a common problem in patients with gout. This study explores recent studies examining the nature and extent of disability in gout and addresses the merits and limitations of current self-reported measures of disability. RECENT
FINDINGS: Gout has a significant impact on patients' ability to perform normal self-care activities, recreational and social activities, and work. Comparative studies indicate that gout patients' physical functioning is strongly reduced and comparable to those with other severe rheumatic conditions. Moreover, gout has been shown to result in substantial work absence and reduced productivity. However, few studies have thoroughly examined the concept of disability in gout. Additionally, assessment of disability due to gout still seems particularly challenging and it is unclear whether current measurement instruments are sufficiently valid and accurate.
SUMMARY: Gout-related disability is an underestimated and understudied problem. More qualitative and quantitative studies are needed that examine the concept of disability in gout and its impact on patients' lives, both during and between disease flares. Moreover, future studies should try to identify gout-specific disability issues and examine the relevance and comprehensiveness of existing measures to further improve the assessment of disability in gout.

Entities:  

Mesh:

Year:  2012        PMID: 22227879     DOI: 10.1097/BOR.0b013e32834ff59d

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  7 in total

1.  Predictors of activity limitation in people with gout: a prospective study.

Authors:  Sarah Stewart; Keith Rome; Alastair Eason; Meaghan E House; Anne Horne; Anthony J Doyle; Julie Knight; William J Taylor; Nicola Dalbeth
Journal:  Clin Rheumatol       Date:  2018-04-21       Impact factor: 2.980

2.  Physical Function, Hyperuricemia, and Gout in Older Adults.

Authors:  Bridget Teevan Burke; Anna Köttgen; Andrew Law; Beverly Gwen Windham; Dorry Segev; Alan N Baer; Josef Coresh; Mara A McAdams-DeMarco
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

3.  Experiences of gout-related disability from the patients' perspective: a mixed methods study.

Authors:  Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

4.  A Randomized, Controlled Trial to Assess the Efficacy of Arthroscopic Debridement in Combination with Oral Medication Versus Oral Medication in Patients with Gouty Knee Arthritis.

Authors:  Xin Wang; Pingping Wanyan; Jian Min Wang; Jin Hui Tian; Long Hu; Xi Ping Shen; Ke Hu Yang
Journal:  Indian J Surg       Date:  2013-07-24       Impact factor: 0.656

5.  Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR).

Authors:  Carlo A Scire; Maria Manara; Marco A Cimmino; Marcello Govoni; Fausto Salaffi; Leonardo Punzi; Maria C Monti; Greta Carrara; Carlomaurizio Montecucco; Marco Matucci-Cerinic; Giovanni Minisola
Journal:  Arthritis Res Ther       Date:  2013-08-23       Impact factor: 5.156

6.  Alternate Warm and Cold Therapy (AWCT) on Uricemia, Sleep, Pain, Functional Ability, and Quality of Life (USPFQoL) in Patients with Gout: A Path Forward.

Authors:  Premalatha Paulsamy; Krishnaraju Venkatesan; ShadiaHamoud Alshahrani; Fazil Ahmad; Mohamed El-Sherbiny; Vani Manoharan; Kalaiselvi Periannan; RashaElsayed Ahmed; Kousalya Prabahar; Dawit Mamiru Teressa
Journal:  J Healthc Eng       Date:  2022-03-09       Impact factor: 2.682

7.  Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments.

Authors:  Liying Zeng; Zekun Lin; Pan Kang; Meng Zhang; Hongyu Tang; Miao Li; Kun Xu; Yamei Liu; Ziyun Jiang; Shaochuan Huo
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.